Episteme 10 (4):417-439 (2013)

Authors
Alexandra Bradner
Kenyon College
Abstract
Drug discovery traditionally has occurred behind closed doors in for-profit corporations hoping to develop best-selling medicines that recoup initial research investment, sustain marketing infrastructures, and pass on healthy returns to shareholders. Only corporate Pharma has the man- and purchasing-power to synthesize the thousands of molecules needed to find a new drug and to conduct the clinical trials that will make the drug legal. Against this view, individual physician-scientists have suggested that the promise of applied genomics work calls for a new form of social organization in order to speed the generation and understanding of new therapeutics. Recent successes in open source drug discovery show it is possible to produce valuable, empirically adequate, and sustainable collective beliefs without secrecy, proprietary attitudes, initial cooperation from Pharma, or outsized monetary incentives. After reviewing and differentiating these successes, I diagnose the source of this healthy new epistemic strategy
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1017/epi.2013.33
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 64,159
Through your library

References found in this work BETA

Business Ethics and Stakeholder Analysis.Kenneth E. Goodpaster - 1991 - Business Ethics Quarterly 1 (1):53-73.
Testimony, Advocacy, Ignorance: Thinking Ecologically About Social Knowledge.Lorraine Code - 2010 - In Adrian Haddock, Alan Millar & Duncan Pritchard (eds.), Social Epistemology. Oxford University Press.

View all 8 references / Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

生命的哲学 ‐后基因时代药物筛选策略与传统中药学理论.Xiao Ming Wang - 2008 - Proceedings of the Xxii World Congress of Philosophy 44:139-142.
The Concept of Placebo.Professor Zbigniew Szawarski - 2004 - Science and Engineering Ethics 10 (1):57-64.
Integrating Research and Development: The Emergence of Rational Drug Design in the Pharmaceutical Industry.Matthias Adam - 2005 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 36 (3):513-537.
Drug Use as Consumer Behavior.Gordon Robert Foxall & Valdimar Sigurdsson - 2011 - Behavioral and Brain Sciences 34 (6):313-314.
The Concept of Placebo.Zbigniew Szawarski - 2004 - Science and Engineering Ethics 10 (1):57-64.
Race, Pharmacogenomics, and Marketing: Putting BiDil in Context.Jonathan Kahn - 2006 - American Journal of Bioethics 6 (5):W1-W5.

Analytics

Added to PP index
2013-12-12

Total views
14 ( #712,413 of 2,454,831 )

Recent downloads (6 months)
1 ( #449,241 of 2,454,831 )

How can I increase my downloads?

Downloads

My notes